Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug suppliers colluded on ministry contracts, says Russia's anti-trust authority

This article was originally published in Scrip

Executive Summary

Russia's antimonopoly authority, the federal antimonopoly service (FAS), has accused 18 drug manufacturers and distributors of various types of collusion including some that resulted in irregularities in state drug purchase tenders in 2008-09 that could cost Rb3.4 billion ($120 million) in overpayments. The alleged collusion occurred in the bidding process for contracts to supply expensive drugs for seven relatively rare and inherited conditions. FAS said it will look into the case on 11 May, but did not say whether any other state bodies will also be involved. The FAS holds no authority to institute criminal proceeding and/or conduct criminal investigation.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC012645

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel